Industry Insights
-
Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
11/10/2026
In Part 2 of two, Dr. Haydar Frangoul discusses long-term safety and durability of gene editing in children with SCD and TDT, plus the infrastructure, specialized expertise, and referral pathways needed to expand access to treatment.
-
Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
11/9/2026
In Part 1 of this two-part series, Dr. Haydar Frangoul discusses early CRISPR gene editing with exa-cel in children with sickle cell disease and beta thalassemia.
-
Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
11/6/2026
Determining whether a drug manufacturing environment is stable, drifting, or developing a recurring loss-of-control signal requires integrated trend evaluation.
-
Want More Sustainable Biopharma Packaging? Try These Levers
11/6/2026
Biopharmaceutical packaging optimization must not compromise the goods inside or compliance, so sustainable packaging developers might need to think outside the box.
-
What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
11/4/2026
The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know.
-
Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
11/3/2026
If geometric control, not retention, is the priority in viral vector separation, research group says high-resolution 3D-printing chromatography monoliths can be useful.
-
How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
11/3/2026
Europe's glass manufacturers, including those making pharmaceutical lab glassware, have experienced a series of energy shocks. Many have adopted sustainability practices.
-
The EU Overhauls Pharma Laws: What You Need To Know
11/2/2026
On Sept. 18, the Council of the EU published the almost-final text of a major overhaul of the EU pharmaceutical laws. The final binding text is expected to be published very soon.
-
Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
11/2/2026
Mayo Clinic experts shared where, when, and how automation can make the biggest impact on autologous CAR T manufacturing.
-
Closing The CAR-T Access Gap With Hospital-Based Manufacturing
10/30/2026
Improvements in closed-loop processing and lower material costs could bring distributed manufacturing within reach. Hospitals still need to stand up production suites.